Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gislason
Jason J. Gislason, Lake Jackson, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20090149684 | Oligomerization of hydrocarbons - Methods of oligomerizing hydrocarbons are disclosed. These methods include contacting olefins with an oligomerization catalyst in an oligomerization zone under oligomerization reaction conditions. | 06-11-2009 |
| 20100076234 | ALKYLATION UNIT AND PROCESS RELATING THERETO - One exemplary embodiment can be an alkylation unit. The alkylation unit can include at least one alkylation reaction zone having an alkylation catalyst, at least one cooler communicating with the at least one alkylation reaction zone, a settler communicating with the at least one alkylation reaction zone and the at least one cooler, a fractionation zone receiving an effluent from the settler passing through a line, and a boot coupled to a substantially horizontal portion of the line. Generally, the boot receives an effluent portion rich in the alkylation catalyst. | 03-25-2010 |
Jason J. Gislason, Bartlesville, OK US
| Patent application number | Description | Published |
|---|---|---|
| 20080305023 | PROCESS FOR SELECTIVE OXIDATION OF CARBON MONOXIDE IN A HYDROGEN CONTAINING STREAM - A method of making a composition, said method comprising, spraying a substance comprising platinum and iron into or onto an alumina-containing compound is disclosed. The resulting composition can then be used in a process for oxidizing carbon monoxide with free oxygen. | 12-11-2008 |
Johannes Gislason, Reykjavik IS
| Patent application number | Description | Published |
|---|---|---|
| 20090281058 | Compositions of partially deacetylated chitin derivatives - The present invention relates to compositions comprising biologically active chitinous oligomers and their endotoxin purified and partially deacetylated chitin polymer precursors, and their use in pharmaceutical compositions, biomaterial compositions, medical devices, and processes to produce the said oligomers. More specifically the present invention relates to novel compositions and processes to produce such compositions. The compositions include therapeutic hetero polymer and hetero oligomer compositions comprising specific sequences of N-acetyl glucosamine and glucosamine, developed to optimize chemical and structural features which are important for the therapeutic activity of these compositions. In addition, the present invention provides methods to use degree of deacetylation of a partially deacetylated chitin polymer in order to modulate physical and biological parameters in a calcium phosphate composite for bone implant applications. | 11-12-2009 |